Biotech & pharma
Hope for powerful new C Diff. treatment
20 Sep 2011
Scientists 'disarm' HIV in step towards vaccine
20 Sep 2011
Fail-safe system may lead to cures for inherited disorders
By By Scott LaFee | 17 Sep 2011
Scientists find a previously unknown fail-safe pathway potentially protects the brain and other organs from genetic and environmental threats
A call to arms for synthetic biology
15 Sep 2011
Scientists synthesise one arm of yeast chromosome, develop new method for "scrambling" DNA
New hope for hepatitis C vaccine
15 Sep 2011
Invention unravels mystery of protein folding
15 Sep 2011
Cancer-killing cells caught on film in greater 3D detail than before
14 Sep 2011
Scientists reveal how a type of white blood cells, called Natural Killer cells, protect the body from tumours and virus-infected cells
Men also wired for childcare
14 Sep 2011
New hope for HIV vaccine
10 Sep 2011
Bacteria shed light on new drug targets for inherited cancers
09 Sep 2011
Scientists have succeeded in purifying a protein found in bacteria that could reveal new drug targets for inherited breast and ovarian cancers as well as other cancers linked to DNA repair faults
Innovative nanoparticle purification system using magnetic fields may aid medication, diagnostics
08 Sep 2011
New drugs for dangerous yeast infections
06 Sep 2011
Developing drugs tailored to patients' genome
By By Marla Paul | 06 Sep 2011
Killing a cancer cell from the inside out
03 Sep 2011
Biologists have designed a synthetic gene that, when delivered to cancer cells, forces them to commit suicide.
Latest articles
Featured articles
.webp)
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.
